Alliqua Enters License Agreement with Celgene
November 19, 2013 at 07:39 AM EST
Alliqua (OTC: ALQA ) entered into a licensing agreement with Celgene Cellular Therapeutics (“CCT”), a subsidiary of Celgene Corporation (NASDAQ: CELG ) (“Celgene”), whereby Alliqua received the
